Gene Signatures of Breast Cancer Development and the Potential for Novel Targeted Treatments

Abstract

The advent of -omics technologies has led to the identification of genes distinguishing different classes of BC into molecular subtypes, genes frequently mutated in BC or associated with hereditary BC, leading to an enormous amount of data exploring resistance, metastasis, BC development and progression, and opening many boundaries for personalized patient care. "